Search clinical trials for: 18F-FAZA (F18-Fluoroazomycin Arabinoside)

Total 1156 results

University of California, San Francisco

Completed

Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy

Refractory Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Plasma Cell Myeloma | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | Recurrent High Grade B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Recurrent... and other conditions

United States
University Health Network, Toronto
Merck Frosst Canada Ltd.

Withdrawn

A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo

Pancreatic Adenocarcinoma | Metastatic Disease | Advanced Disease
University Health Network, Toronto

Active, not recruiting

Cervix Hypoxia FAZA

Cervix Cancer

Canada
The Hospital for Sick Children

Enrolling by invitation

Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas

Rhabdomyosarcoma | Non-Rhabdo. Soft Tissue Sarcoma

Canada
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

Malignant Solid Neoplasm | Malignant Breast Neoplasm | Malignant Pancreatic Neoplasm | Malignant Colorectal Neoplasm

United States
University Health Network, Toronto

Recruiting

Prostate Hypoxia FAZA

Prostate Cancer

Canada
Medical University of Vienna

Unknown

Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer

Uterine Cervical Neoplasms

Austria
Sunnybrook Health Sciences Centre
University of Toronto; Sunnybrook Research Institute

Recruiting

Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer (FAITH)

Tongue Cancer

Canada
AHS Cancer Control Alberta

Unknown

Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

Lung Neoplasm | Cell Hypoxia

Canada
Institut Curie

Active, not recruiting

Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers (PROTONCHORDE01)

Skull Base Chordoma | Vertebral Chordoma

France
AHS Cancer Control Alberta

Withdrawn

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

Hypoxic Tumours
University of Aarhus
Danish Head and Neck Cancer Group

Completed

DAHANCA 24: Prognostic Value of 18F-FAZA in Head and Neck Squamous Cell Carcinoma (HNSCC)

Cancer of the Head and Neck

Denmark
University Health Network, Toronto

Recruiting

18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer

Lung Cancer

Canada
University Health Network, Toronto

Recruiting

FAZA PET/MRI Sarcoma

Sarcoma

Canada
University Health Network, Toronto

Recruiting

FAZA PET/MRI Pancreas

Locally Advanced Pancreatic Adenocarcinoma | Unresectable Pancreatic Cancer | Pancreatic Adenocarcinoma Non-resectable

Canada
AHS Cancer Control Alberta

Terminated

[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours

Renal Cell Carcinoma | Neuroendocrine Tumours

Canada
University Health Network, Toronto

Completed

The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial

Adenocarcinoma | Uterine Cervical Neoplasms | Carcinoma, Adenosquamous | Squamous Cell Carcinoma

Canada
Vejle Hospital
Aarhus University Hospital

Terminated

Predictive Value of 18F-FAZA in Rectum Cancer (FAZA)

Locally Advanced Rectum Cancer

Denmark
AHS Cancer Control Alberta

Terminated

A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer

Breast Neoplasm

Canada
IRCCS San Raffaele

Completed

FAZA PET IMAGING IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS (FAZA)

Renal Cell Carcinoma (RCC)

Italy
Avid Radiopharmaceuticals

Completed

Augmenting Flortaucipir Dosimetry Estimates

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Terminated

Imaging Characteristics of a Follow-up 18F-AV-1451 Scan

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy

United States
Avid Radiopharmaceuticals

Completed

18F-AV-1451 Autopsy Study

Alzheimer's Disease

United States, Australia
Avid Radiopharmaceuticals

Completed

Tau Screening Study in Patients With Early Symptomatic AD

Alzheimer Disease

United States, Canada
Avid Radiopharmaceuticals

Completed

Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects (MCI)

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

Tau Screening Study in Subjects With Early Symptomatic AD

Alzheimer Disease

United States
Avid Radiopharmaceuticals

Completed

Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease

Alzheimer Disease

United States
Zhejiang University

Completed

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

Pancreas Adenocarcinoma | Diagnosis | Staging | 18F-FDG | 18F-FAPI

China
Avid Radiopharmaceuticals

Completed

Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease

Alzheimer Disease | Mild Cognitive Impairment
Avid Radiopharmaceuticals

Terminated

Flortaucipir 18F PET Imaging in BIOCARD Study

Cognitive Decline

United States
Avid Radiopharmaceuticals
The Cleveland Clinic

Completed

Tau Imaging in Professional Fighters

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

Flortaucipir PET Imaging in Subjects With FTD

Frontotemporal Dementia

United States
Avid Radiopharmaceuticals

Completed

Clinical Evaluation of Flortaucipir F 18

Depression | Traumatic Brain Injury | Alzheimer's Disease

United States
Siemens Molecular Imaging

Terminated

Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects

Breast Cancer

United States
Avid Radiopharmaceuticals

Completed

Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.

Frontotemporal Dementia | Alzheimer's Disease

United Kingdom
Avid Radiopharmaceuticals

Completed

Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects

Alzheimer Disease

United States
Mayo Clinic
Blue Earth Diagnostics, Inc

Recruiting

18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain

Metastatic Intracranial Malignant Neoplasm | Recurrent Intracranial Neoplasm

United States
Rigshospitalet, Denmark

Enrolling by invitation

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

Neuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Carcinoma Metastatic | GEP-NET

Denmark
Washington University School of Medicine
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

PET Assessment of Acute Lung Transplant Rejection

Lung Disease

United States
University of North Carolina, Chapel Hill
Boston Children's Hospital; Medical College of Wisconsin; National Football League

Enrolling by invitation

NFL LONG Prospective Study

Concussion, Brain

United States
GlaxoSmithKline
Cambridge University Hospitals NHS Foundation Trust

Terminated

A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques

Arthritis, Rheumatoid

United Kingdom
American College of Radiology
National Cancer Institute (NCI); American College of Radiology Imaging Network

Terminated

Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer (ACRIN6682)

Cervical Cancer

United States
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

Lymphoma, Non-Hodgkin | Central Nervous System Neoplasms

Norway
Markus Weber
University Hospital Inselspital, Berne; ETH Zurich

Not yet recruiting

Investigation of Cannabinoid 2-receptor Expression in the Brain and Spine of ALS-patients Compared to Healthy Controls With PET (18F-RoSMALS) (18F-RoSMALS)

Amyotrophic Lateral Sclerosis

Switzerland
Stanford University

Completed

The Role of Audiovisual Biofeedback on Image Quality During 4D Anatomic and Functional Imaging

Lung Cancer

United States
Thomas Hope

Active, not recruiting

Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms (UC-GlioFET)

Recurrent Glioblastoma | Recurrent WHO Grade III Glioma | Low Grade Glioma | Intracranial Neoplasm | Recurrent World Health Organization (WHO) Grade II Glioma

United States
Chang Gung Memorial Hospital

Recruiting

Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer

Ovarian Cancer

Taiwan
Avid Radiopharmaceuticals

Terminated

A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808 (T808)

Alzheimers Disease

United States
Avid Radiopharmaceuticals

Completed

The Feasibility of Florbetapir Quantitation in Europe

Alzheimer's Disease

Netherlands

Search clinical trials for: 18F-FAZA (F18-Fluoroazomycin Arabinoside)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations